Similar articles

• [What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].

  Müller P. Müller P. Nervenarzt. 1983 Sep;54(9):477-85. Nervenarzt. 1983. PMID: 6138720 German. No abstract available.
• Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.

  Gaebel W, Möller HJ, Buchkremer G, Ohmann C, Riesbeck M, Wölwer W, Von Wilmsdorff M, Bottlender R, Klingberg S. Gaebel W, et al. Eur Arch Psychiatry Clin Neurosci. 2004 Apr;254(2):129-40. doi: 10.1007/s00406-004-0509-y. Eur Arch Psychiatry Clin Neurosci. 2004. PMID: 15146342 Clinical Trial.
• [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].

  Roncoroni D. Roncoroni D. Psychiatr Prax. 1984 Mar;11(2):56-8. Psychiatr Prax. 1984. PMID: 6144121 German.
• [Therapeutic alliance, a stake in schizophrenia].

  Charpentier A, Goudemand M, Thomas P. Charpentier A, et al. Encephale. 2009 Feb;35(1):80-9. doi: 10.1016/j.encep.2007.12.009. Epub 2008 May 19. Encephale. 2009. PMID: 19250998 Review. French.
• Partial compliance in schizophrenia and the impact on patient outcomes.

  Llorca PM. Llorca PM. Psychiatry Res. 2008 Nov 30;161(2):235-47. doi: 10.1016/j.psychres.2007.07.012. Epub 2008 Oct 11. Psychiatry Res. 2008. PMID: 18849080 Review.